Cargando…
Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers
Partial and/or heterogeneous irradiation of established (i.e., large, vascularized) tumors by α‐particles that exhibit only a 4–5 cell‐diameter range in tissue, limits the therapeutic effect, since regions not being hit by the high energy α‐particles are likely not to be killed. This study aims to m...
Autores principales: | Salerno, Dominick, Howe, Alaina, Bhatavdekar, Omkar, Josefsson, Anders, Pacheco‐Torres, Jesus, Bhujwalla, Zaver M., Gabrielson, Kathleen L., Sofou, Stavroula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115683/ https://www.ncbi.nlm.nih.gov/pubmed/35600657 http://dx.doi.org/10.1002/btm2.10266 |
Ejemplares similares
-
The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia
por: Bhatavdekar, Omkar, et al.
Publicado: (2022) -
Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
por: Salerno, Dominick, et al.
Publicado: (2021) -
Radionuclide carriers for targeting of cancer
por: Sofou, Stavroula
Publicado: (2008) -
Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy
por: Chen, Zhihang, et al.
Publicado: (2016) -
Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors
por: Ngen, Ethel J., et al.
Publicado: (2021)